Suppr超能文献

库欣病。

Cushing's disease.

机构信息

Service des Maladies Endocriniennes et Métaboliques, Centre de Référence des Maladies Rares de la Surrénale, Hôpital Cochin, 27, rue du Fg St Jacques, 75014 Paris, France.

出版信息

Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):607-23. doi: 10.1016/j.beem.2009.06.001.

Abstract

Cushing's syndrome refers to the clinical manifestations induced by chronic exposure to excess glucocorticoids. There are three pathological conditions that can result in the chronic overproduction of endogenous cortisol in man: the most frequent is Cushing's disease where adrenocorticotropic hormone (ACTH) is overproduced by a pituitary corticotroph adenoma, rarely ACTH can be produced in an 'ectopic' manner by a non-pituitary tumour, finally cortisol can be directly over-secreted by one or (rarely) the two adrenals that have become tumourous, either benign or malignant. The positive diagnosis of Cushing's syndrome requires that chronic hypercortisolism is unequivocally demonstrated biologically, using 24-h urinary cortisol, late-evening plasma or salivary cortisol, midnight 1-mg or the classic 48-h-low-dose dexamethasone suppression test, etc., all with essentially the same diagnosis potencies. The search for the responsible tumour then relies on the assessment of the corticotroph function, and imaging: suppressed ACTH plasma levels indicate an 'adrenal' Cushing, and the responsible unilateral adrenocortical tumour is always visible at computed tomography (CT) scan, whereas its benign or malignant nature may be difficult to diagnose before surgery. Imaging can suspect bilateral 'adrenal' Cushing, when the two adrenals are small, as in the primary pigmented nodular adrenal dysplasia associated with Carney complex, or enlarged, as in the ACTH-independent macronodular adrenocortical hyperplasia. Measurable or increased ACTH plasma levels indicate either Cushing's disease or the ectopic ACTH syndrome. When the dynamics of the corticotroph function (high-dose dexamethasone suppression test, the CRH test) are equivocal, and/or the imaging is non-contributive, it may be difficult to distinguish between the two. This is the situation where sampling ACTH plasma levels in the inferior petrosal sinus may be necessary. The best treatment option of Cushing's disease is when the responsible corticotroph adenoma can be entirely removed by the trans-sphenoidal approach, with sufficient skill to preserve the normal anterior pituitary function. When it fails, all other options directed towards the pituitary (radiation therapies), or the adrenals (medications or surgery), have numerous side effects. There is at present no recognised efficient medical treatment towards the corticotroph adenoma -still an orphan disease.

摘要

库欣综合征是指慢性暴露于过量糖皮质激素引起的临床表现。有三种病理情况可导致人体内内源性皮质醇的慢性过度产生:最常见的是库欣病,其中促肾上腺皮质激素(ACTH)由垂体促肾上腺皮质细胞瘤过度产生,很少见的情况下 ACTH 可以由非垂体肿瘤以“异位”方式产生,最后皮质醇可以由一个或(很少见)两个变成肿瘤的肾上腺直接过度分泌,无论是良性还是恶性。库欣综合征的阳性诊断需要明确地从生物学上证明慢性高皮质醇血症,使用 24 小时尿皮质醇、傍晚血浆或唾液皮质醇、午夜 1 毫克或经典的 48 小时低剂量地塞米松抑制试验等,所有这些试验的诊断效能基本相同。然后,寻找责任肿瘤依赖于评估促肾上腺皮质激素的功能和影像学:抑制的 ACTH 血浆水平表明是“肾上腺”库欣,并且负责的单侧肾上腺皮质肿瘤在计算机断层扫描(CT)扫描中总是可见,而其良性或恶性性质可能难以在手术前诊断。当两个肾上腺较小,如与卡尼综合征相关的原发性色素性结节性肾上腺发育不良,或增大,如 ACTH 非依赖性大结节性肾上腺皮质增生时,影像学可能怀疑是双侧“肾上腺”库欣。可测量或增加的 ACTH 血浆水平表明是库欣病或异位 ACTH 综合征。当促肾上腺皮质激素功能的动力学(高剂量地塞米松抑制试验、CRH 试验)不确定,并且/或者影像学无帮助时,可能难以区分两者。在这种情况下,可能需要在下鼻甲蝶窦采血样测量 ACTH 血浆水平。库欣病的最佳治疗选择是当负责的促肾上腺皮质激素腺瘤可以通过经蝶窦完全切除时,具有足够的技能来保留正常的前垂体功能。当这种方法失败时,针对垂体的所有其他选择(放射治疗)或肾上腺(药物或手术)都有许多副作用。目前,针对促肾上腺皮质激素腺瘤没有有效的治疗方法——仍然是一种孤儿病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验